Denosumab Induced Severe Hypocalcemia in a Patient With Metastatic Prostate Cancer

Background: Denosumab can lead to severe hypocalcemia in patients with underlying risk factors such as vitamin D deficiency, low PTH, hypomagnesemia, and CKD. Denosumab is a monoclonal antibody against RANKL, reducing the activity of osteoclasts and thus reducing the release of calcium in the bloods...

Descripción completa

Detalles Bibliográficos
Autores principales: Naher, Kamrun, Thrupthi, Komandur, Samsuddoha, Kazi, Galiveeti, Sneha, Leung, Vivien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Bone and Mineral Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090016/
http://dx.doi.org/10.1210/jendso/bvab048.384

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090016/
http://dx.doi.org/10.1210/jendso/bvab048.384

Ejemplares similares